Alpha synuclein and inflammaging

The α-synuclein protein is an established molecule in Lewy body pathology, especially Parkinson's disease (PD). While the pathological role of α-synuclein (α-syn) in PD has been well described, novel evidence may suggest that α-syn interacts with inflammasomes in response to aging. As age is an...

Full description

Saved in:
Bibliographic Details
Main Authors: Geneviève L. Putnam, Robert W. Maitta
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844025003615
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832573065220849664
author Geneviève L. Putnam
Robert W. Maitta
author_facet Geneviève L. Putnam
Robert W. Maitta
author_sort Geneviève L. Putnam
collection DOAJ
description The α-synuclein protein is an established molecule in Lewy body pathology, especially Parkinson's disease (PD). While the pathological role of α-synuclein (α-syn) in PD has been well described, novel evidence may suggest that α-syn interacts with inflammasomes in response to aging. As age is an inevitable physiological state and is also considered the greatest risk factor for PD, this calls for investigation into how α-syn, aging, and PD could be linked. There is a growing amount of data regarding α-syn normal function in the body that includes involvement in cellular transport such as protein complexes assembly, vesicular trafficking, neurotransmitter release, as well as immune cell maturation. Regarding abnormal α-syn, a number of autosomal dominant mutations have been identified as causes of familial PD, however, symptomatology may not become apparent until later in life due to compensatory mechanisms in the dopaminergic response. This potentially links age-related physiological changes not only as a risk factor for PD, but for the concept of “inflammaging ”. This is defined as chronic inflammation that accompanies aging observed in many neurodegenerative pathologies, that include α-syn's ability to form oligomers and toxic fibrils seen in PD. This oligomeric α-syn stimulates pro-inflammatory signals, which may worsen PD symptoms and propagate chronic inflammation. Thus, this review will explore a potential link between α-syn's role in the immune system, inflammaging, and PD.
format Article
id doaj-art-2ee6b0a7cebf4bfba00440ed64e8ee5a
institution Kabale University
issn 2405-8440
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-2ee6b0a7cebf4bfba00440ed64e8ee5a2025-02-02T05:28:42ZengElsevierHeliyon2405-84402025-01-01112e41981Alpha synuclein and inflammagingGeneviève L. Putnam0Robert W. Maitta1Case Western Reserve University School of Medicine, Cleveland, OH, USAUniversity Hospitals Cleveland Medical Center, Cleveland, OH, USA; Case Western Reserve University School of Medicine, Cleveland, OH, USA; Corresponding author. Department of Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Andrews 647A, PTH 5077, 11100 Euclid Avenue, Cleveland, OH, 44106, USA.The α-synuclein protein is an established molecule in Lewy body pathology, especially Parkinson's disease (PD). While the pathological role of α-synuclein (α-syn) in PD has been well described, novel evidence may suggest that α-syn interacts with inflammasomes in response to aging. As age is an inevitable physiological state and is also considered the greatest risk factor for PD, this calls for investigation into how α-syn, aging, and PD could be linked. There is a growing amount of data regarding α-syn normal function in the body that includes involvement in cellular transport such as protein complexes assembly, vesicular trafficking, neurotransmitter release, as well as immune cell maturation. Regarding abnormal α-syn, a number of autosomal dominant mutations have been identified as causes of familial PD, however, symptomatology may not become apparent until later in life due to compensatory mechanisms in the dopaminergic response. This potentially links age-related physiological changes not only as a risk factor for PD, but for the concept of “inflammaging ”. This is defined as chronic inflammation that accompanies aging observed in many neurodegenerative pathologies, that include α-syn's ability to form oligomers and toxic fibrils seen in PD. This oligomeric α-syn stimulates pro-inflammatory signals, which may worsen PD symptoms and propagate chronic inflammation. Thus, this review will explore a potential link between α-syn's role in the immune system, inflammaging, and PD.http://www.sciencedirect.com/science/article/pii/S2405844025003615α-synucleinAgingInflammagingInflammationParkinson's disease
spellingShingle Geneviève L. Putnam
Robert W. Maitta
Alpha synuclein and inflammaging
Heliyon
α-synuclein
Aging
Inflammaging
Inflammation
Parkinson's disease
title Alpha synuclein and inflammaging
title_full Alpha synuclein and inflammaging
title_fullStr Alpha synuclein and inflammaging
title_full_unstemmed Alpha synuclein and inflammaging
title_short Alpha synuclein and inflammaging
title_sort alpha synuclein and inflammaging
topic α-synuclein
Aging
Inflammaging
Inflammation
Parkinson's disease
url http://www.sciencedirect.com/science/article/pii/S2405844025003615
work_keys_str_mv AT genevievelputnam alphasynucleinandinflammaging
AT robertwmaitta alphasynucleinandinflammaging